Ipamorelin

Peptide peptide SubQ Published Clinical Data

Half-life

2 hr

Time to Peak

30 min

Steady State

~1 days

Dose Range

100–300 mcg

Frequency

Daily

Overview

Selective growth hormone releasing peptide (GHRP) that stimulates GH release without significantly affecting cortisol, prolactin, or ACTH — making it one of the cleanest GH secretagogues. Frequently combined with CJC-1295 (no DAC) for synergistic effects. Requires reconstitution with BAC water.

Mechanism of Action

Selective ghrelin/GHS receptor agonist on the anterior pituitary. Unlike GHRP-2 and GHRP-6, it does not significantly stimulate appetite or raise cortisol/prolactin.

Dosing Information

Route Dose Range Half-life Tmax Frequency
Subcutaneous (SubQ) 100–300 mcg 2 hr 30 min Daily, Twice daily, three times daily

Storage & Handling

2-8C — Store lyophilized powder refrigerated. Reconstitute with BAC water. Use reconstituted solution within 4-6 weeks.

Used in Regimens

1 regimen

Data Sources

  • Peer-reviewed Ipamorelin pharmacokinetic and pharmacodynamic study

Related Tools

Track Ipamorelin with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.